BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7238646)

  • 1. Studies on graft versus host (GvH) reactions. I. Impairment of hemopoietic stroma in mice suffering from GvH disease.
    Hirabayashi N
    Exp Hematol; 1981 Feb; 9(2):101-10. PubMed ID: 7238646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemopoietic support capacity of W/WV femurs and tibias.
    Adler SS; Sawada U; Trobaugh FE
    Exp Hematol; 1980 Jul; 8(6):666-73. PubMed ID: 7009183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origins of hemopoietic and stromal cells in subcutaneous femur implants.
    Hotta T; Murate T; Utsumi M; Hirabayashi N; Yamada H
    Exp Hematol; 1983 Feb; 11(2):107-13. PubMed ID: 6832240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of erythroid colony-stimulating activity in the serum of mice with graft-versus-host disease.
    Kanamaru A; Okamoto T; Matsuda K; Hara H; Nagai K
    Exp Hematol; 1984 Nov; 12(10):763-7. PubMed ID: 6334610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells.
    Knospe WH; Husseini SG; Chiu KM; Fried W
    Exp Hematol; 1994 Jul; 22(7):573-81. PubMed ID: 8013573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the age of donors and recipients on the regional graft-versus-host reaction in mice.
    Skowron-Cendrzak A; Kubera M; Bubak-Satora M; Godowicz W
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):185-91. PubMed ID: 1810211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental hypoplastic marrow failure in the mouse.
    Kubota K; Mizoguchi H; Miura Y; Kano S; Takaku F
    Exp Hematol; 1978 Nov; 6(10):791-800. PubMed ID: 33819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):167-73. PubMed ID: 9515226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Semisyngeneic transplantation of hematopoietic cells of native and cultured embryonic liver].
    Samoĭlina NL
    Biull Eksp Biol Med; 1988 Feb; 105(2):228-31. PubMed ID: 2894868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.
    Ghayur T; Seemayer TA; Xenocostas A; Lapp WS
    Am J Pathol; 1988 Oct; 133(1):39-46. PubMed ID: 3263049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
    Hrubá A; Paluska E; Fricová V; Fiala J
    Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity in graft-versus-host reaction. II. Lysis of target cells of parental genotyppe by F1 hybrid macrophages.
    Fung KY; Sabbadini E
    Transplantation; 1976 Nov; 22(5):449-54. PubMed ID: 11578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-vs-host reactions in F1 mice induced by parental lymphoid cells: nature of recruited F1 cells.
    Romano TJ; Ponzio NM; Thorbecke GJ
    J Immunol; 1976 Jun; 116(6):1618-23. PubMed ID: 5562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors.
    Piersma AH; Ploemacher RE; Brockbank KG
    Exp Hematol; 1983 Oct; 11(9):884-90. PubMed ID: 6357830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bone marrow stroma in hemopoietic stem cell regulation.
    Chertkov JL; Gurevitch OA; Udalov GA
    Exp Hematol; 1980 Jul; 8(6):770-8. PubMed ID: 7009186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.